Myasthenia Gravis – Vertex Pharmaceuticals VX25-AIS-301

Participating in a clinical trial with Profound means making a real difference in the lives of others facing similar health challenges.

The purpose of this study is to evaluate the pharmacodynamic (PD) effect, safety, and tolerability of Povetacicept in participants with generalized myasthenia gravis (gMG).

Key Inclusion Criteria:

  • Age 18-80 years
  • Diagnosis of generalized myasthenia gravis with generalized muscle weakness and fitting MGFA clinical classification II-IV
  • Additional inclusion criteria are defined in the protocol

Call us at 725-226-5989 or complete the form and our team will reach out soon to help determine your eligibility.

View Study on ClinicalTrials.gov

Trial Interest Form

Locations

Las Vegas Neurology Consultants

2020 Wellness Wy
Las Vegas, Nevada